Caamtech, Inc.
Issaquah, WA, US· latest recorded location
CAAMTECH, INC. is named on 30 US grants and 73 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 30
- Published applications
- 73
- Inventors
- 6
- Granted in 2026 so far
- 2
- Most recent grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2018 | 0 | 1 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 1 | 8 |
| 2022 | 3 | 4 |
| 2023 | 4 | 19 |
| 2024 | 11 | 16 |
| 2025 | 9 | 16 |
| 2026 | 2 | 8 |
By publication year. 2026 runs to 8 Oct.
Technology areas
Share of 103 documents
Recent patents
- Tryptamine derivatives28 Jul 2026US 12,692,231 B2
- Quaternary tryptamines and their therapeutic uses16 Jun 2026US 12,655,102 B2
- Crystalline 4-hydroxy-N,N-di-n-propyltryptammonium (4-HO-DPT) salts16 Dec 2025US 12,497,360 B2
- Crystalline tryptamine compounds16 Dec 2025US 12,497,361 B2
- Compositions comprising a serotonergic tryptamine compound16 Sep 2025US 12,414,936 B2
- Compositions containing kratom compounds1 Oct 2026US 2026/0294996 A1
- Compositions containing kratom compounds24 Sep 2026US 2026/0284136 A1
- Crystalline 5-methoxy-n,n-diallyltryptamine compounds18 Jun 2026US 2026/0167605 A1
- Crystalline 4-hydroxy-n,n-di-n-propyltryptammonium (4-ho-dpt) salts18 Jun 2026US 2026/0167606 A1
- 2-(2,5-diethoxy-4-(ethylthio)phenyl)ethane-1-aminium chloride30 Apr 2026US 2026/0116851 A1
Most cited
By later US patents
- Compositions and methods comprising a psilocybin derivative26US 10,933,073 B22021
- Crystalline N-methyl tryptamine derivatives11US 11,332,441 B22022
- Crystalline forms of psilacetin4US 11,358,934 B22022
- Compositions and methods comprising a combination of serotonergic drugs2US 11,471,439 B22022
- Crystalline psilacetin derivatives2US 11,753,375 B22023